ArticleBMJ (Clinical research ed.)2008
Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study.
Article in BMJ (Clinical research ed.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers, 8 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
93 citing papers in PubMed, 8 syntheses or guidelines pooled it.
- Serious adverse events following human papillomavirus vaccination: A systematic review and meta-analysis of post-marketing evidence.Human vaccines & immunotherapeutics · 2026Pooled it
- Vaccine attitudes among young adults in Asia: a systematic review.Human vaccines & immunotherapeutics · 2021Pooled it
- HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe.Human vaccines & immunotherapeutics · 2019Pooled it
- The Uptake of Human Papillomavirus Vaccination and Its Associated Factors Among Adolescents: A Systematic Review.Journal of primary care & community health · 2017Pooled it
- Ethnicity-specific factors influencing childhood immunisation decisions among Black and Asian Minority Ethnic groups in the UK: a systematic review of qualitative research.Journal of epidemiology and community health · 2017Pooled it
- Tempest in a teapot: A systematic review of HPV vaccination and risk compensation research.Human vaccines & immunotherapeutics · 2016Pooled it
- HPV vaccination among ethnic minorities in the UK: knowledge, acceptability and attitudes.British journal of cancer · 2011Pooled it
- Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence.Sexual health · 2010Pooled it
- Long-term effect of mobile phone-based education and influencing factors of willingness to receive HPV vaccination among female freshmen in Shanxi Province, China.Human vaccines & immunotherapeutics · 2022Trial
- Trial
- What do parents of school-aged children want to know about HPV vaccination in Canada? Results of an online survey on Facebook.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2026Article
- Religion, Politics, and Vaccines: Elaborating the Integrative Public Policy Acceptance (IPAC) Framework Through HPV Vaccine Program Acceptance Among Religious Leaders in Bangladesh.International journal of health policy and management · 2026Article
- Human papillomavirus vaccine uptake and the impact of school-based health services in Switzerland: a cross-sectional study.BMJ public health · 2026Article
- Human papillomavirus genotype-specific prevalence and infection risks: a 10-year population-based study from the United States.Journal of the National Cancer Institute · 2025Article
- Evaluating HPV Vaccination Behavior and Willingness to Be Vaccinated and Associated Factors Among University Students in Italy.Vaccines · 2025Article
- Article
- Easy access to vaccination was important for adherence during the 2016-2019 HPV catch-up vaccination in Norway.Human vaccines & immunotherapeutics · 2022Article
- Sociodemographic determinants of catch-up HPV vaccination completion between 2016-2019 in Norway.Human vaccines & immunotherapeutics · 2022Article
- Measuring school level attributable risk to support school-based HPV vaccination programs.BMC public health · 2022Article
- Strategies for Improving Participation in Human Papillomavirus Vaccination Among Young Adults in the Capital of Iran: A Qualitative-Exploratory Study.International journal of preventive medicine · 2022Article
33 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo assess the feasibility and acceptability of delivering a human papillomavirus (HPV) vaccine to adolescent girls.
designProspective cohort study.
setting36 secondary schools in two primary care trusts in Greater Manchester, United Kingdom.
participants2817 schoolgirls in year 8 (12 and 13 year olds).
interventionDelivery of the bivalent vaccine at 0, 1, and 6 months over one school year.
main outcome measuresVaccine uptake for doses 1 and 2 of a three dose schedule.
resultsVaccine uptake was 70.6% (1989/2817) for the first dose and 68.5% (1930/2817) for the second dose. Uptake was significantly lower in schools with a higher proportion of ethnic minority girls (P<0.001 for trend) or higher proportion of girls entitled to free school meals (P=0.029 for trend). The main reason for parents' refusal of vaccination was insufficient information about the vaccine and its long term safety. Maintaining the vaccine schedule was challenging as 16.3% (dose 1) and 23.6% (dose 2) of girls missed their vaccination day and had to be offered alternative appointments. No serious adverse events were reported.
conclusionDelivery of the first two doses of HPV vaccine to adolescent schoolgirls is encouraging, but the success of the vaccination programme depends on high coverage for the third dose.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.